Skip to main content

MUSC News

Read about the education, research and clinical advancements happening across the MUSC academic health system. Discover how our experts are empowering healthy communities, driving innovation and health transformation and reshaping the future workforce for South Carolina and beyond.

Filters

  • Filtered by

A man wearing a white lab coat, blue shirt and necktie smiles as he stands in front of shelves filled with glass containers. There is a large window on the left side of the photo.
MUSC News + Featured News
hEDS and its fellow travelers

If you’ve spent any time in the hypermobile Ehlers-Danlos syndrome (hEDS) community, you’ve likely noticed a pattern.

The conversation inevitably begins with joints – the growing pains, roaming kneecaps, seemingly countless orthopedic adventures that many patients know all too well. But it rarely ends there.

One patient mentions dizziness and fainting. Another struggles with migraines. Someone else talks about chronic digestive problems and urinary issues. Yet another describes mysterious allergic-like reactions that come out of nowhere. Crushing fatigue. Tachycardia. Endometriosis. ADHD. The list can feel endless.

For most people living with hEDS, the condition does not travel alone.

While joint instability and overwhelming pain are hallmarks of the connective tissue disorder, increasingly, researchers and clinicians are recognizing that hEDS is typically accompanied by a collection of related conditions and symptoms referred to as comorbidities. While not every person with hEDS experiences all of them, these conditions appear often enough that they have become a major focus of research and clinical care.

Ask Chip Norris, Ph.D., a question about hEDS, and the conversation almost immediately moves beyond connective tissue.

Read more arrow_forward

Recent News Releases

More News Releases arrow_forward

Topics

Podcasts

More Podcasts arrow_forward

Events

See More Events arrow_forward

Social

Stories

Until doctors hear about lived experience, they don’t know to study it.

Angela Timashenka Geiger cancer survor who spoke at the American Association for Cancer Research (AACR) Annual Meeting this spring

More MUSC news

View news by topic